Filters
Results 1 - 10 of 21
Results 1 - 10 of 21.
Search took: 0.024 seconds
| Sort by: date | relevance |
No abstract available
Source
Apr 1974; 5 p; ISBN 064299627X; 
No abstract available
Source
May 1974; 6 p; ISBN 0642996334;
[en] Reagent grade molybdenum trioxide used as a target material for the preparation of Tc-99m pharmaceuticals contains trace amounts of rhenium. A simple charcoal adsorptions process has been developed to remove rhenium selectively from molybdenum before neutron irradiation. Details are given of the design and operation of a pilot plant in which 17 kg of molybdenum trioxide was produced having a rhenium content of less than 1 x 10-6 μg g-1. Although contamination of the Tc-99m by inactive rhenium and 188Re was effectively eliminated, 188Re resulting from the irradiation of tungsten impurity in the molybdenum trioxide target was still present
Source
Dec 1985; 10 p; ISBN 0 642 59819 3;
[en] A simple exchange-labelling procedure for the radioiodination of meta-lobobenzylguanidine (MIBG) has been developed which facilitates the production of (131I) MIBG both quickly and efficiently. Stability studies indicate that labelled material if stored at reduced temperature undergoes little breakdown. Comparative biodistribution studies with a commercial source has been used to authenticate both the identity and purity of the product. 19 refs., 3 tabs., 7 figs
Source
Aug 1989; 10 p; ISBN 0 642 59897 5;
No abstract available
Journal
International Journal of Applied Radiation and Isotopes; ISSN 0020-708X; ; v. 35(1); p. 68
; v. 35(1); p. 68
No abstract available
Journal
Australian and New Zealand Journal of Medicine; ISSN 0004-8291; ; v. 13(6); p. 658
; v. 13(6); p. 658
No abstract available
Journal
Australian and New Zealand Journal of Medicine; ISSN 0004-8291; ; v. 14(6); p. 931-932
; v. 14(6); p. 931-932
| 1 | 2 | 3 | Next |